AAPL 166.74 -4.13 (-2.41%)MSFT 107.48 -1.98 (-1.81%)FB 145.36 +0.33 (+0.23%)ZNGA 3.66 -0.08 (-2.01%)NVDA 147.91 -0.95 (-0.64%)WBA 79.09 -3.23 (-3.92%)GOOG 1049.8 -12.2 (-1.15%)PIH 5 -0.12 (-2.34%)
AAPL 166.74 -4.13 (-2.41%)MSFT 107.48 -1.98 (-1.81%)FB 145.36 +0.33 (+0.23%)ZNGA 3.66 -0.08 (-2.01%)NVDA 147.91 -0.95 (-0.64%)WBA 79.09 -3.23 (-3.92%)GOOG 1049.8 -12.2 (-1.15%)PIH 5 -0.12 (-2.34%)

Company Profile ABUS Quote Arbutus Bio

Arbutus Biopharma Corporation Quote

Arbutus Biophar (ABUS)

4.46 0.04 Healthcare

CEO

Sector

Healthcare

Industry

Biotechnology

Exchange

Nasdaq Global Select

Description

Arbutus Biopharma Corp is a biopharmaceutical business engaged in advancing novel RNA interference therapeutics and discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection.